Wordt geladen...
Precision Medicines’ Impact on Orphan Drug Designation
The incentives provided under the Orphan Drug Act (ODA) have been credited for catalyzing the marketing approval of drugs for the treatment of rare diseases by the US Food and Drug Administration. Orphan drug designation, the granting of special status to drugs or biologics (“drugs”) for the treatme...
Bewaard in:
| Gepubliceerd in: | Clin Transl Sci |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853264/ https://ncbi.nlm.nih.gov/pubmed/31297924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12667 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|